BSE filing, NSE: CARERATING. Summary written from the filing by ALFA Finder's alert engine.
CARE Ratings Ltd: key numbers
- Share price
- ₹1,613.20
- Market cap
- ₹4,861 Cr
- Revenue (annual)
- ₹473.1 Cr
- Net profit (annual)
- ₹171.2 Cr
- P/E (TTM)
- 27.4×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 23.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CARE Ratings Ltd
All →CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
CARE Ratings Q2 FY27 Results: Net Profit ₹72.4 Cr, Up 26.6% YoY
CARE Ratings Ltd reported revenue from operations of ₹164.1 Cr (+20.3% YoY) and net profit of ₹72.4 Cr (+26.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹72.4 Cr · +26.6% YoY
CARE Ratings Merger & Restructuring
CARE Ratings executed SPAs to sell 9.90% stakes each in subsidiary CareEdge Global IFSC to SBI and NSE IFSC. CARE will retain 80.20% post-closing.
CARE Ratings Other Announcement
CARE Ratings Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
CARE Ratings Employee Stock Options
CARE Ratings Limited allotted 14,200 equity shares to employees following the exercise of options under its Employee Stock Option Scheme 2020.
CARE Ratings Earnings Call Transcript: Key Takeaways
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
Other board meeting date announcements
All →Mehta Securities Board Meeting Date
Mehta Securities has scheduled a board meeting on 6 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Mehta Integrated Finance Board Meeting Date
Mehta Integrated Finance scheduled a board meeting on November 6, 2026 to approve half-year results. The trading window remains closed until results are declared.
Sanjivani Paranteral Board Meeting Date
Sanjivani Paranteral will hold a board meeting on 5 November 2026 to approve Q2 unaudited results. The agenda is only proposed until the meeting is held.
Kalpataru Projects International Board Meeting Date
Kalpataru Projects will hold a board meeting on November 5, 2026 to approve quarterly and half-year results. An investor call follows on November 6, and the trading window stays closed.
NACDAC Infrastructure Board Meeting Date
NACDAC Infrastructure will hold a board meeting on November 4, 2026 to approve unaudited standalone half-year results ended September 30, 2026. Trading window remains closed until 48 hours after declaration.
Deep Health AI India Board Meeting Date
Deep Health AI will hold a board meeting on 3 November 2026 for unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.